TP53 and gastric cancer: Interestingly, while early‐onset GC is generally considered to have a poorer prognosis [9, 27] than the late‐onset one, our study found a poorer treatment response in patients with late‐onset GC with TP53 mutations compared to those with early‐onset GC.